LIFECORE BIOMEDICAL, INC. \DE\
Financial highlights
| Metric | FY 05/25/25 | FY 05/26/24 | FY 05/28/23 | FY 02/26/23 | FY 11/27/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $128.9 | $128.3 | $103.3 | — | — |
| Operating income | -$17.2 | -$8.8 | -$21.8 | — | — |
| Net income | -$38.7 | $12.0 | -$99.6 | — | — |
| Balance Sheet | |||||
| Total debt | $188.3 | $187.5 | $150.2 | — | — |
| Cash Flow Statement | |||||
| Free cash flow | -$13.6 | -$18.1 | -$24.4 | — | — |
| Share repurchases | $0.5 | — | — | — | — |
Shares outstanding 37.9M · Free float 7.5%
Annual filing data through FY ended May 25, 2025; float as of September 23, 2026.